These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18190861)
41. [Participation in the global study. Activities and issues from the bedside]. Yamamoto N Gan To Kagaku Ryoho; 2007 Feb; 34(2):316-9. PubMed ID: 17301553 [TBL] [Abstract][Full Text] [Related]
42. Plant science. Using tobacco to treat cancer. Arntzen CJ Science; 2008 Aug; 321(5892):1052-3. PubMed ID: 18719274 [No Abstract] [Full Text] [Related]
44. Will children with cancer benefit from the new European Paediatric Medicines Regulation? Vassal G Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857 [TBL] [Abstract][Full Text] [Related]
45. [Molecular therapeutics in patients with cancer unresponsive to conventional treatments]. Valdespino-Gómez VM; Valdespino-Castillo VE Gac Med Mex; 2008; 144(4):333-44. PubMed ID: 18942268 [TBL] [Abstract][Full Text] [Related]
47. DNA vaccines: precision tools for activating effective immunity against cancer. Rice J; Ottensmeier CH; Stevenson FK Nat Rev Cancer; 2008 Feb; 8(2):108-20. PubMed ID: 18219306 [TBL] [Abstract][Full Text] [Related]
48. Pancreatic cancer: progress in cancer therapy. Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073 [TBL] [Abstract][Full Text] [Related]
49. The yin and yang of cancer therapeutics. Bronchud MH Curr Opin Drug Discov Devel; 2005 Mar; 8(2):184-98. PubMed ID: 15782543 [TBL] [Abstract][Full Text] [Related]
50. Biomarkers in early cancer drug development: limited utility. Glassman RH; Ratain MJ Clin Pharmacol Ther; 2009 Feb; 85(2):134-5. PubMed ID: 19151638 [TBL] [Abstract][Full Text] [Related]
51. Enrichment designs: efficiency in development of cancer treatments. Temple RJ J Clin Oncol; 2005 Aug; 23(22):4838-9. PubMed ID: 15983397 [No Abstract] [Full Text] [Related]
52. Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatments. Stebbing J; Wood C; Atkins M; Bukowski R; Litwin S; Bower M; Parsa A; Levitsky H Cancer; 2008 Mar; 112(5):955-61. PubMed ID: 18286505 [TBL] [Abstract][Full Text] [Related]
53. Anticancer research: a few hints for discovery of new targets. Lacal JC Cancer Lett; 2004 Apr; 206(2):125-7. PubMed ID: 15013517 [No Abstract] [Full Text] [Related]
54. [Translational research for cancer therapeutics]. Tsuruo T Gan To Kagaku Ryoho; 2003 Apr; 30(4):449-54. PubMed ID: 12722673 [TBL] [Abstract][Full Text] [Related]
55. Recent advances in cancer vaccines: an overview. Itoh K; Yamada A; Mine T; Noguchi M Jpn J Clin Oncol; 2009 Feb; 39(2):73-80. PubMed ID: 19015149 [TBL] [Abstract][Full Text] [Related]
56. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo. Radfar S; Wang Y; Khong HT J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868 [TBL] [Abstract][Full Text] [Related]
58. Immunosuppressive mechanisms in cancer: consequences for the development of therapeutic vaccines. Gross S; Geldmacher A; Sharav T; Losch F; Walden P Vaccine; 2009 May; 27(25-26):3398-400. PubMed ID: 19200836 [TBL] [Abstract][Full Text] [Related]
59. Crackdown on unproven cancer treatments focuses on internet marketers. Ross K J Natl Cancer Inst; 2008 Sep; 100(17):1200-2. PubMed ID: 18728276 [No Abstract] [Full Text] [Related]
60. Twenty-five years of reviewing cancer treatment. Rubens RD; Coleman RE Cancer Treat Rev; 1999 Feb; 25(1):1-2. PubMed ID: 10212585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]